Literature DB >> 15121272

Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders.

Keiseki Kaneyama1, Natsuki Segami, Jun Sato, Masaaki Nishimura, Hiroshi Yoshimura.   

Abstract

The aim of this study was to find out whether there was a correlationship between the concentrations of interleukin-6 (IL-6), IL-11, and IL-17 in synovial fluid and osseous changes in the condyle. The synovial fluid was obtained from 61 patients with temporomandibular joint disorders (TMD) and seven healthy volunteers (controls). The concentrations of IL-6, IL-11, and IL-17 were measured by enzyme-linked immunosorbent assay. IL-6 was detected in 43 of 59 (73%), IL-11 in 23 of 52 (44%) and IL-17 in 14 of 51 (27%) samples of synovial fluid. The concentrations of IL-6 and IL-11 in the joints with osseous changes in the condyle were significantly higher than in the joints without osseous changes (P < 0.05) and also higher than in the joints of the control group (P < 0.05). In addition, there was a correlation of concentrations between IL-6 and IL-11 (P < 0.05). These results suggest that IL-6 and IL-11 may participate in the pathogenesis of TMD and induce osseous changes in the condyle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121272     DOI: 10.1016/S0266-4356(03)00258-4

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  8 in total

1.  Effect of a functional variant of tumor necrosis factor-β gene in temporomandibular disorders: A pilot study.

Authors:  Kaan Yerliyurt; Ayse Feyda Nursal; Akin Tekcan; Nevin Karakus; Mehmet K Tumer; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

2.  Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.

Authors:  Nelson L Rhodus; Bin Cheng; Frank Ondrey
Journal:  Mediators Inflamm       Date:  2007-02-28       Impact factor: 4.711

3.  Elastin‑derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells.

Authors:  Kazuhiko Kobayashi; Rei Jokaji; Mayuko Miyazawa-Hira; Shigeyuki Takatsuka; Akira Tanaka; Kazuhiro Ooi; Hiroyuki Nakamura; Shuichi Kawashiri
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

Review 4.  Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms.

Authors:  Carla Alvarez; Gustavo Monasterio; Franco Cavalla; Luis A Córdova; Marcela Hernández; Dominique Heymann; Gustavo P Garlet; Timo Sorsa; Pirjo Pärnänen; Hsi-Ming Lee; Lorne M Golub; Rolando Vernal; Alpdogan Kantarci
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 8.786

Review 5.  Biomarkers for Temporomandibular Disorders: Current Status and Future Directions.

Authors:  Abdalwhab Zwiri; Mohammad A I Al-Hatamleh; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Suan Phaik Khoo; Adam Husein; Zuryati Ab-Ghani; Nur Karyatee Kassim
Journal:  Diagnostics (Basel)       Date:  2020-05-15

Review 6.  Muscle-Bone Crosstalk in the Masticatory System: From Biomechanical to Molecular Interactions.

Authors:  Sonja Buvinic; Julián Balanta-Melo; Kornelius Kupczik; Walter Vásquez; Carolina Beato; Viviana Toro-Ibacache
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-01       Impact factor: 5.555

7.  The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production.

Authors:  Mutsumi Kawashima; Naomi Ogura; Miwa Akutsu; Ko Ito; Toshirou Kondoh
Journal:  J Oral Pathol Med       Date:  2013-01-18       Impact factor: 4.253

8.  Gene Expression Profiling of IL-17A-Treated Synovial Fibroblasts from the Human Temporomandibular Joint.

Authors:  Toshio Hattori; Naomi Ogura; Miwa Akutsu; Mutsumi Kawashima; Suguru Watanabe; Ko Ito; Toshirou Kondoh
Journal:  Mediators Inflamm       Date:  2015-12-29       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.